- Report
- September 2025
- 150 Pages
Middle East
From €4418EUR$4,950USD£3,797GBP
- Report
- November 2024
- 154 Pages
Global
From €2231EUR$2,500USD£1,917GBP
- Report
- August 2025
- 197 Pages
Global
From €3164EUR$3,545USD£2,719GBP
€3515EUR$3,939USD£3,021GBP
- Report
- August 2025
- 191 Pages
Global
From €3164EUR$3,545USD£2,719GBP
€3515EUR$3,939USD£3,021GBP
- Report
- August 2025
- 194 Pages
Global
From €3164EUR$3,545USD£2,719GBP
€3515EUR$3,939USD£3,021GBP
- Report
- August 2025
- 183 Pages
Global
From €3164EUR$3,545USD£2,719GBP
€3515EUR$3,939USD£3,021GBP
- Report
- May 2024
- 85 Pages
Spain
From €3124EUR$3,500USD£2,684GBP
- Report
- November 2023
- 71 Pages
France
From €3124EUR$3,500USD£2,684GBP
- Report
- December 2022
- 117 Pages
Global
From €4016EUR$4,500USD£3,451GBP
- Report
- August 2025
- 194 Pages
Global
From €3164EUR$3,545USD£2,719GBP
€3515EUR$3,939USD£3,021GBP
- Report
- December 2024
- 175 Pages
Global
From €4462EUR$5,000USD£3,835GBP
- Report
- December 2024
- 200 Pages
Global
From €3347EUR$3,750USD£2,876GBP
- Report
- January 2024
- 200 Pages
Global
From €3704EUR$4,150USD£3,183GBP
- Report
- October 2023
- 145 Pages
Global
From €2811EUR$3,150USD£2,416GBP
- Report
- December 2024
- 150 Pages
Global
From €3347EUR$3,750USD£2,876GBP
- Report
- July 2024
- 100 Pages
Global
From €3347EUR$3,750USD£2,876GBP
- Report
- November 2023
- 119 Pages
Global
From €4016EUR$4,500USD£3,451GBP
- Report
- April 2023
- 90 Pages
Europe
From €4239EUR$4,750USD£3,643GBP
- Report
- August 2022
- 115 Pages
Global
From €4239EUR$4,750USD£3,643GBP
- Report
- June 2025
- 400 Pages
Global
From €4417EUR$4,949USD£3,796GBP

Brachytherapy is a form of radiation therapy used in Nuclear Medicine and Radiopharmacology. It involves the placement of radioactive sources directly into or near a tumor, allowing for a higher dose of radiation to be delivered to the tumor while minimizing the dose to surrounding healthy tissue. Brachytherapy is used to treat a variety of cancers, including prostate, breast, and gynecological cancers. It is also used to treat benign conditions such as uterine fibroids.
Brachytherapy is typically performed in an outpatient setting, and can be used as a primary treatment or in combination with other treatments such as surgery or external beam radiation therapy. The procedure is minimally invasive and can be completed in a single session.
Some companies in the brachytherapy market include Elekta, Varian Medical Systems, C. R. Bard, and Nordion. Show Less Read more